Macrophage Pharma's Series A - II Round

Macrophage Pharma raised a round of funding on August 23, 2017. Investors include Merck Ventures.

Macrophage Pharma is an immuno-oncology company focused on the discovery and development of novel therapies designed to enhance anti-tumour immune responses. The Company's technology platform is desig…

Articles about Macrophage Pharma's Series A - II Round: